Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionD.a. Davidson & Co.
Latest Disclosed Ownership5,139 shares
Latest Disclosed Value $ 2,294,769
D.a. Davidson & Co. reports 2.13% decrease in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On May 5, 2026 - D.a. Davidson & Co. filed a 13F-HR form disclosing ownership of 5,139 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $1,950,764 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 5,251 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -2.13% during the quarter. The current value of the position is $1,882,416 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,139 -112 -2.13 2,295 -3.61 0.0139
2026-01-29 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,251 154 3.02 2,381 19.24 0.0146
2025-10-22 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,097 241 4.96 1,996 -7.64 0.0128
2025-07-30 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,856 51 1.06 2,162 -7.21 0.0152
2025-04-28 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,805 -349 -6.77 2,330 12.24 0.0187
2025-01-31 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,154 -321 -5.86 2,076 -18.50 0.0169
2024-11-13 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 5,475 611 12.56 2,546 11.72 0.0210
2024-08-01 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,864 -22 -0.45 2,280 11.61 0.0202
2024-05-13 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,886 2,427 98.70 2,042 104.20 0.0184
2024-02-09 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,459 -904 -26.88 1,001 -14.46 0.0098
2023-11-08 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,363 110 3.38 1,169 2.19 0.0127
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,253 -521 -13.80 1,145 -3.78 0.0121
2023-04-25 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,774 -567 -13.06 1,189 -5.11 0.0134
2023-02-03 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,341 2,240 106.62 1,254 106.09 0.0148
2022-11-07 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,101 -141 -6.29 608 -3.80 0.0080
2022-07-28 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,242 61 2.80 632 11.07 0.0079
2022-05-12 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,181 948 76.89 569 109.96 0.0062
2022-01-31 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,233 -3 -0.24 271 20.98 0.0029
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,236 1,236 224 0.0026
2021-08-10 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -932 -100.00 0 -100.00
2021-05-07 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 932 932 200 0.0026
2021-02-10 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -841 -100.00 0 -100.00
2020-11-02 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 841 70 9.08 229 2.23 0.0040
2020-08-10 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 771 771 224 0.0042
2019-08-12 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -21,676 -100.00 0 -100.00
2019-05-13 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 21,676 -624 -2.80 3,987 7.90 0.0685
2019-01-29 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,300 -233 -1.03 3,695 -14.92 0.0720
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,533 -206 -0.91 4,343 12.37 0.0773
2018-08-02 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,739 -672 -2.87 3,865 1.28 0.0758
2018-05-04 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,411 -301 -1.27 3,816 7.40 0.0789
2018-02-08 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,712 -1,326 -5.30 3,553 -6.65 0.0745
2017-11-08 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 25,038 133 0.53 3,806 18.60 0.0747
2017-08-11 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 24,905 447 1.83 3,209 20.01 0.0725
2017-05-12 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 24,458 -640 -2.55 2,674 44.85 0.0648
2017-02-15 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 25,098 9,058 56.47 1,846 32.05 0.0419
2016-11-18 2016-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 16,040 25 0.16 1,398 1.60 0.0348
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,040 1,398
2016-08-13 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 16,015 337 2.15 1,376 10.52 0.0405
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,678 738 4.94 1,245 -33.74 0.0388
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,940 -61 -0.41 1,879 20.37 0.0612
2015-11-13 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,001 134 0.90 1,561 -14.89 0.0546
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 14,867 752 5.33 1,834 10.22 0.0603
2015-05-06 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 14,115 -1,254 -8.16 1,664 -8.82 0.0546
2015-02-12 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,369 -4,572 -22.93 1,825 -18.45 0.0597
2014-11-12 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,941 -120 -0.60 2,238 17.85 0.0758
2014-07-29 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 20,061 863 4.50 1,899 40.04 0.0643
2014-05-05 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,198 2,677 16.20 1,356 10.60 0.0485
2014-02-13 2013-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 16,521 5,284 47.02 1,226 44.07 0.0458
2014-02-12 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 16,521 1,226
2013-11-14 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,237 852 8.20 851 2.65 0.0383
2013-08-16 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,385 10,385 829 0.0400
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.